Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
07/2003
07/02/2003CN1112848C Pest controlling agent containing substituted aminoquinazolone or thioketone derivative or its salt as active component
07/01/2003US6586594 Reacting 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl) ethanone and 6-(1-bromoethyl)-4-chloro-5-fluoropyrimidine in the presence of zinc, iodine, lewis acids, aprotic solvents and optionally lead to form sterospecific fungicides
07/01/2003US6586454 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
07/01/2003US6586441 Adenosine receptor ligands and their use in the treatment of disease
07/01/2003US6586440 Uracil substituted at 5-position by C2-4 alkynyl used as inactivator of uracil reductase enzyme
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
07/01/2003US6586187 2-benzyloxycarbonylamino-3-(2-(4-(2-(3-benzylureido)-ethyl) -piperazin-1-yl)acetylamino)-propionic acid, for example; method of synthesis using Wang resins; various uses including anticancer, antiinflammatory and antiviral agents
06/2003
06/26/2003WO2003052106A1 Method of screening compounds
06/26/2003WO2003051866A1 2-guanidino-4-heterocyclylquinazolines
06/26/2003WO2003051849A1 Process for producing quinazolin-4-one and derivative thereof
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051119A1 New herbicidal compounds and method
06/26/2003WO2003040109A3 Quinazoline derivatives as antitumor agents
06/26/2003US20030120066 Synthetic peptides
06/26/2003US20030119982 Wet adhesion monomer and derived copolymers for latex paints
06/26/2003US20030119885 1,2-Diaminocyclopentanes, e.g., N-(2-(3-(4-chlorophenyl)-propylamino)cyclopentyl)-2-(5-(3,4 -dimethoxyphenyl)pyrimidin-2-ylsulfanyl)acetamide; inhibit eosinphil recruitment; skindisorders; asthma; antiinflammatory agents, antiallergens
06/26/2003US20030119854 Compounds and methods for modulating CXCR3 function
06/26/2003US20030119844 Bind with high selectivity and/ or high affinity to CRF1 receptors (Corticotropin Releasing Factor 1 Receptors), useful for treating psychiatric and neurological diseases, including depression, anxiety and post trauma stress
06/26/2003US20030119834 Angiogenesis inhibitors; 3-alkyl-4-one quinazoline derivatives
06/26/2003US20030119833 Treating cardiovascular diseases
06/26/2003US20030119818 CRF antagonistic quino-and quinazolines
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119674 Substituted benzoylcyclohexane diones for use as herbicides
06/26/2003US20030115687 Use of an extract of Myrsine africana in oxidation dyeing for dyeing keratin fibres
06/26/2003CA2470311A1 Method of screening compounds
06/26/2003CA2470214A1 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
06/26/2003CA2470030A1 2-guanidino-4-heterocyclylquinazolines
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1320528A2 Substituted phthalides as anti-convulsive drugs
06/25/2003EP1320520A1 Sulfonylguanidine
06/25/2003CN1426388A Process for preparation of 2-halobenzoic acids
06/25/2003CN1425655A Method for preparing pyrimidine derivative
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003US6583161 Benzenesulfonamides and benzamides as therapeutic agents
06/24/2003US6583148 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003WO2003050099A1 Phenylalkynes
06/19/2003WO2003049740A1 Quinazoline derivatives for the treatment of abnormal cell growth
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049738A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049678A2 Mitotic kinesin inhibitors
06/19/2003WO2003007798A3 Ophthalmic use of 5 fluorourcil
06/19/2003US20030114685 Processes for preparing calcium salt forms of statins
06/19/2003US20030114681 C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
06/19/2003US20030114674 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
06/19/2003US20030114673 2-amino-5,6-dihalo-3,4-dihydroquinazolines with blood platelet reducing properties
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114490 New phenylalanine derivatives
06/19/2003US20030114473 Anticancer agents
06/19/2003US20030114472 Viricides
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030114446 Induce immunology response
06/19/2003US20030114445 Bactericides
06/19/2003US20030114414 Preparing an N3-substituted-4-pyrimidone by contacting a 4-pyrimidone with a nonaqueous base and an alkylating agent including a leaving group; 6-(substituted amino)uracil by reacting a 2-alkoxy-6-amino-4-pyrimidone with an amine salt
06/19/2003CA2469893A1 Phenylalkynes
06/19/2003CA2469670A1 Quinazoline derivatives for the treatment of abnormal cell growth
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2468266A1 Substituted bicyclic pyrimidinones as a mitotic kinesin ksp inhibitors
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318985A2 4-amino-quinazolines
06/18/2003EP1318984A1 4-amino-quinazolines
06/18/2003EP1318981A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP0827498B1 New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients
06/18/2003CN1425008A 3-aminoquinazolin-2, 4-dione antibacterial agents
06/18/2003CN1425007A Preparation of sulfonamides
06/17/2003US6579984 Economical, industrially feasible
06/17/2003US6579983 5-cyano-2-aminopyrimidine derivatives
06/17/2003US6579982 Treating inflammation, cancer
06/17/2003US6579900 Can be used to reduce pain, reducing nausea in an individual undergoing chemotherapy, suppressing appetite, reducing intraocular pressure, and suppressing the immune system in an individual with an organ transplant.
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/12/2003WO2003048155A1 Thrombin inhibitors
06/12/2003WO2003048133A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
06/12/2003WO2003047516A2 Pyrimidine compounds
06/12/2003WO2003032994A3 Novel tri-substituted pyrimidines, method for production and use thereof as medicament
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/12/2003US20030109607 Thermally stabilized polyvinyl chloride compositions
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109547 Amidinophenylpyruvic acid derivatives
06/12/2003US20030109538 Pyrmidine derivatives as selective inhibitors of cox-2
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003US20030109523 Bicyclic antagonists selective for the alphavbeta3 integrin
06/12/2003CA2468349A1 Pyrimidine compounds
06/11/2003EP1318147A1 Novel pyrimidine derivative and novel pyridine derivative
06/11/2003EP1318146A1 Process for producing pyrimidine derivative and intermediate thereof
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317434A1 Preparation of risperidone
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
1 ... 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 ... 427